References
- Eddy D M. ACS report on the cancer-related health checkup. CA 1980; 30: 194–240
- National Center for Statistics Health. Characteristics of females ever having a Pap smear and interval since last Pap smear. United States, 1973. Monthly Vital Statistics Report. Health Interview Survey, Provisional Data (HRA) 76–1120, Vol 24. No 7 (Suppl). US Departnient of Health, Education, and Welfare, Washington, DC October, 1975
- Dickinson L, Mussey M E, Soule E H. Evaluation of the effectiveness of cytologic screening for cervical cancer. I Incidence and mortality trends in relation to screening. Mayo Clin Proc 1972; 42: 534–555
- Kim K, Rigel R D, Patrick J R. The changing trends of uterine cancer and cytology: A study of morbidity and mortality trends over a twenty-year period. Cancer 1978; 42: 2439–2449
- Lundin F E, Christopherson W M, Mendez W M. Morhidity from cervical cancer: Effects of cervical cytology and socioeco-nomic status. J Natl Cancer lnst 1965; 35: 1015–1025
- Pollack E S. Cancer incidence trends in the United States: Some methodological problems. Trends in Cancer Incidence, K Magnus. Hemisphere, Washington, DC 1982
- Johannesson G, Geirsson G, Day N. The effect of mass screening in Iceland, 1965–74, on the incidence and mortality of cervical carcinoma. Int J Cancer 1978; 21: 418–425
- National Cancer Institute. Cancer Statistics Review 1973–1986. National Cancer Institute, Bethesda, MD May, 1989
- Laara E, Day E, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes. Lancet 1987; 2: 1247–1248
- Miller A B, Lindsay J, Hill G B. Mortdity froni cancer of the uterus in Canada and its relationship to screening tor cancer of the cervix. Int J Cancer 1976; 17: 602–612
- Muller C, Mandelblatt J, Schectcr C J. Costs and Effectiveness of Cervical Cancer Screening in Elderly Women. Office of Technology Assessment. Washington, DC February, 1990
- Aristizabal N, Cuello C, Correa P. The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer 1984; 34: 5–9
- Clarke E A, Anderson T W. Does screening by “Pap” smears help prevent cervical cancer. Lancet 1979; 2: 1–4
- Gluck M E, Wagner J L, Duffy B D. The Use of Preventive Services by the Elderly. Office of Technology Assessment, Washington, DC January, 1989
- Hayward R A, Shapiro M, Freeman H F. Who gets screened for cervical and breast cancer. Arch Intern Med 1988; 148: 1177–1181
- US Congress, Office of Technology Asxssment. Preventive Health Services for Medicare Beneficiaries: Policy and Research Issues. Office of Technology Assessment, Washington, DC February, 1990
- Sisk J E, Riegelman R K. Cost effectiveness of vaccination against pneumococcal pneumonia: An update. Ann Intern Med 1986; 104: 79–86
- Medicare to help pay for Pap screenings. Mod Healthcare July 9, 1990; 20: 9
- Nasiell K, Nasiell M, Vaclavinkova V. Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 1983; 61: 609–614
- Weintraub N J, Viola E, Freedman M L. Cervical cancer screening in women aged 65 and over. J Am Ceriatr Soc 1987; 35: 2370–875
- Robertson A J, Reid G S, Stoker C A. Evaluation of a call programme for cervical cytology screening in women aged 50–60. Br Med J 1989; 299: 163–165
- Hamblin J E, Brock C D, Litchfield L. Papanicolaou smear adequacy: Effect of different techniques in specific fertility states. J Fam Pract 1985; 20: 257–260
- Mandelblatt J, Gopaul I, Wistreich M. Gynecological care of elderly women: Another look at Papanicolaou smear testing. JAMA 1986; 256: 367–371
- Jones D ED, Creasman W T, Dombroski R A. Evaluation of the atypical Pap smear. Am J Obstet Gynecol 1987; 157: 544
- Stafl A, Friedrich J R, Mattingly R F. Detection of cervical neo-plasia—Reducing the risk of error. Clin Obstet Gynecol 1973; 16: 238–260
- Walker E M, Dodgson J, Duncan I D. Does mild atypia on a cervical smear warrant further investigation. Lancet 1986; 2: 672–673